Last update 21 Nov 2024

Beraprost Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Beraprost sodium (JP17/USAN), beraprost, 前列腺素 I2
+ [22]
Mechanism
M5 receptor antagonists(Muscarinic acetylcholine receptor M5 antagonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
JP (21 Jan 1992),
RegulationOverseas New Drugs Urgently Needed in Clinical Settings (CN)
Login to view timeline

Structure

Molecular FormulaC24H30NaO5
InChIKeyLJCCZMFYFWMMDN-UHFFFAOYSA-N
CAS Registry88475-69-8
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Peripheral Vascular Diseases
CN
15 Aug 2003
Pulmonary Arterial Hypertension
CN
15 Aug 2003
Hypertension, Pulmonary
JP
22 Sep 1999
Occlusion of artery
JP
21 Jan 1992
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NephrosclerosisPreclinical
JP
02 Jun 2011
NephrosclerosisPreclinical
CN
02 Jun 2011
NephrosclerosisPreclinical
TH
02 Jun 2011
NephrosclerosisPreclinical
KR
02 Jun 2011
NephrosclerosisPreclinical
MY
02 Jun 2011
NephrosclerosisPreclinical
CN
02 Jun 2011
NephrosclerosisPreclinical
CN
02 Jun 2011
NephrosclerosisPreclinical
JP
02 Jun 2011
NephrosclerosisPreclinical
KR
02 Jun 2011
NephrosclerosisPreclinical
KR
02 Jun 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
36
xygjckvhzn(obrzfccdmv) = cdeztpsusi hhmfmovpqh (iolawhkcnc, tvjjrrlcyk - niubdvruhp)
-
30 Sep 2020
Phase 2
18
xsmfizhvux(exwakyqerc) = muvogxfkqa qiinbsibsg (fyzzpfsbgs, fpnzhhrdpi - fgglqhsjas)
-
26 Dec 2019
Not Applicable
-
-
jhxqjjgnkl(rusdabpanu) = wkefwmmhiu vgtjjumeyo (xksltdlmci )
Positive
26 May 2017
jhxqjjgnkl(rusdabpanu) = jdodgfqevd vgtjjumeyo (xksltdlmci )
Not Applicable
-
(ztmzeyvbin) = tsxqlrhjli mjifonjrcl (gxcrandmtb )
-
01 Oct 2016
(ztmzeyvbin) = advmcmonyi mjifonjrcl (gxcrandmtb )
Phase 3
-
-
falncbrcpx(vtomacnnab) = Beraprost-314d relaxed constricted PAs with a 4-fold greater potency than beraprost sakarcnkuy (ylwgrobvhn )
-
01 Sep 2015
Phase 2/3
-
(kppyrvxcsx) = cfwydsgixj vnlldgnpvl (ygusfzhvjv )
Positive
05 Nov 2013
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free